Molina Healthcare, Inc. (MOH) Director Sells $458,208.30 in Stock
Molina Healthcare, Inc. (NYSE:MOH) Director Charles Z. Fedak sold 3,795 shares of the company’s stock in a transaction that occurred on Monday, November 19th. The shares were sold at an average price of $120.74, for a total value of $458,208.30. Following the sale, the director now directly owns 18,464 shares of the company’s stock, valued at $2,229,343.36. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Shares of MOH stock traded up $5.04 during trading hours on Wednesday, reaching $125.59. 809,423 shares of the company’s stock were exchanged, compared to its average volume of 1,111,419. The company has a market cap of $7.38 billion, a price-to-earnings ratio of 224.27, a price-to-earnings-growth ratio of 1.28 and a beta of 1.52. Molina Healthcare, Inc. has a 1 year low of $71.07 and a 1 year high of $154.06. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.78.
Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, October 31st. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.65 by $0.90. The business had revenue of $4.70 billion during the quarter, compared to the consensus estimate of $4.72 billion. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The company’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period in the prior year, the business posted ($1.62) EPS. On average, equities analysts forecast that Molina Healthcare, Inc. will post 8.12 earnings per share for the current fiscal year.
Several research firms have commented on MOH. Jefferies Financial Group raised Molina Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $152.00 to $169.00 in a research note on Tuesday, November 13th. Wells Fargo & Co upped their price objective on Molina Healthcare from $92.00 to $120.00 and gave the company a “market perform” rating in a research note on Thursday, August 2nd. Morgan Stanley upped their price objective on Molina Healthcare from $108.00 to $132.00 and gave the company an “overweight” rating in a research note on Thursday, August 2nd. Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $155.00 price objective for the company in a research note on Tuesday, October 23rd. Finally, Bank of America upped their price objective on Molina Healthcare from $94.00 to $110.00 and gave the company an “underperform” rating in a research note on Wednesday, August 1st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $131.92.
TRADEMARK VIOLATION WARNING: “Molina Healthcare, Inc. (MOH) Director Sells $458,208.30 in Stock” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/11/21/molina-healthcare-inc-moh-director-sells-458208-30-in-stock.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Recommended Story: What is the float in trading stocks?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.